CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Zevra Therapeutics

For profitContributed to NME

Also known as: ZEVRA DENMARK | ZEVRA THERAP | Zevra Therapeutics

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Dec 22, 2022

First marketed drug

Feb 23, 2018

First NDA

Sep 20, 2024

Last known activity

Jul 30, 2025

Timeline

2000s

  1. Oct 30, 2006

    Zevra Therapeutics— Founded

2010s

  1. Feb 23, 2018

    acetaminophen— NDA Secondary Org

2020s

  1. Nov 20, 2023

    Acer Therapeutics— Acquired

  2. Sep 20, 2024

    arimoclomol— NDA Organization

Drugs by trial phase (6 distinct, 10 trials)

Phase 3 (0 own, 1 via acquisition)

Marketed drugs (3)

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (3)

Details

Founded
Coralville, IA, US Oct 30, 2006
First NDA
Sep 20, 2024
Last known activity
Jul 30, 2025

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Breakthrough therapy